SCHEMBL4322696

SCHEMBL4322696

Cc1ccc(S(=O)(=O)Oc2nc3ccccc3c(N)c2[N+](=O)[O-])cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.53
NFE2L2 Q16236 1/20 0.53
HSP90AA1 P07900 1/20 0.42
CRHBP P24387 1/20 0.42
CRHR2 Q13324 1/20 0.42
NPY1R P25929 1/20 0.41
GAA P10253 3/20 0.38
MEN1 O00255 1/20 0.38
ESR1 P03372 1/20 0.38
KMT2A Q03164 1/20 0.38
ESR2 Q92731 1/20 0.38
ALDH1A1 P00352 4/20 0.38
KDM4E B2RXH2 1/20 0.38
CXCL8 P10145 1/20 0.38
NOD2 Q9HC29 1/20 0.38
NOD1 Q9Y239 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
LMNA P02545 3/20 0.37
MAPT P10636 2/20 0.37
C1R P00736 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4315431 0.85 KEAP1 (0.60) KEAP1NFE2L2GAAMEN1ESR1
SCHEMBL7484135 0.77 KEAP1 (0.51) KEAP1NFE2L2HSP90AA1CRHBPCRHR2
SCHEMBL17585445 0.77 MAPT (0.46) KEAP1NFE2L2HSP90AA1CRHBPCRHR2
SCHEMBL311200 0.72 MGMT (0.64) LMNA
SCHEMBL8620036 0.72 HSP90AA1 (0.58) KEAP1NFE2L2HSP90AA1CRHBPCRHR2
SCHEMBL3953291 0.71 KDM4E (0.52) GAAMEN1KMT2AALDH1A1KDM4E
SCHEMBL4051900 0.70 ADORA2A (0.48) KEAP1NFE2L2ALDH1A1
SCHEMBL7824280 0.70 POLB (0.38) MEN1KMT2AALDH1A1KDM4ESMN1; SMN2
SCHEMBL26459259 0.70 KEAP1 (1.00) KEAP1NFE2L2GAAMEN1ESR1
SCHEMBL7410681 0.70 KEAP1 (0.41) KEAP1NFE2L2NPY1RGAAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8735421-B2 Imidazoquinolinyl sulfonamides 3M INNOVATIVE PROPERTIES COMPANY (US) 2014-05-27 US disclosed
US-20090062272-A1 IMIDAZOQUINOLINYL SULFONAMIDES 3M INNOVATIVE PROPERTIES COMPANY 2009-03-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090062272-A1 IMIDAZOQUINOLINYL SULFONAMIDES IL2, EIF2AK2, IFNG KEAP1 2959/4885NFE2L2 1433/4885HSP90AA1 1086/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.